Subscribe To
Lianbio to participate in upcoming investor conferences
SHANGHAI, China and PRINCETON, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovativ...
June 1, 2023, 4:15 pm
Solid biosciences to participate at the jefferies healthcare conference
CHARLESTOWN, Mass., June 01, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic ...
June 1, 2023, 12:00 pm
Landos biopharma to present at the 2023 jefferies healthcare conference
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral <...
May 31, 2023, 8:15 pm
Generation bio to present at the 2023 jefferies healthcare conference
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic ...
May 31, 2023, 11:30 am
Ardelyx to present at the jefferies 2023 healthcare conference
WALTHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
May 31, 2023, 8:00 am
Generation bio to present at the 2023 jefferies healthcare conference
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic ...
May 31, 2023, 7:30 am
2 healthcare ai stocks to buy on the dip
Moderna is working with IBM technology to potentially discover new mRNA medicines. Medtronic is using AI in various specialties and says it could be t...
May 31, 2023, 5:30 am
Krystal clear: krystal biotech clears resistance in good volume
Last week, shares of the Pittsburgh-based genetic medicines developer surged more than 25% after the FD...
May 30, 2023, 7:36 am
Mgc pharmaceuticals announces boardroom changes, reflecting its shift of focus
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC), a specialist in plant-inspired medicines, has announced changes to its board and UK advisers, ...
May 30, 2023, 3:02 am
Ema panel endorses novavax's (nvax) covid jab for full approval
Novavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization in COVID-19 patients from European ...
May 29, 2023, 10:50 am
Genetic testing services market anticipated to hit us$ 31.5 billion by 2031, expanding at a cagr of 8.4%: tmr report
The growing awareness about personalized medicines and the increased rate of genetic disorders across t...
May 26, 2023, 9:30 pm
Gilead's (gild) veklury gets positive chmp view for extended use
Gilead (GILD) obtains positive opinion for the use of Veklury in COVID-19 patients with severe renal impairment, including those on dialysis, from the...
May 26, 2023, 11:35 am
Roche to present new data in blood cancers and solid tumours from its broad portfolio at asco 2023
Basel, 26 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new data on six approved and investigational ...
May 26, 2023, 1:00 am
Jnana therapeutics announces milestone achieved under first collaboration with roche
Achievement of research milestone for immune program triggers milestone payment BOSTON, May 24, 2023 (GLOBE NEWSWIRE) — Jnana Therapeutics, a clinic...
May 24, 2023, 11:00 am
Arbor biotechnologies to present at the stifel 2023 tailoring genes: genetic medicines day
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of...
May 23, 2023, 11:00 am
Verve therapeutics to participate in the stifel 2023 tailoring genes: virtual genetic medicines day
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiova...
May 23, 2023, 10:30 am
Kalvista pharmaceuticals to present at stifel 2023 tailoring genes: genetic medicines day virtual conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
May 23, 2023, 6:30 am
2 bear market defying stocks to buy in may
Sanofi's wide lineup of medicines across several therapeutic areas makes it attractive. Axsome Therapeu...
May 22, 2023, 7:45 am
Ardelyx announces fda acceptance and six-month review for resubmission of its new drug application of xphozah® (tenapanor)
User Fee Goal Date: October 17, 2023 WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company found...
May 17, 2023, 11:30 am
Beam therapeutics to participate in upcoming may investor conferences
CAMBRIDGE, Mass., May 17, 2023 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic ...
May 17, 2023, 10:30 am